|
FAQ
Detailed Search
|
| Topic: |
kidney and urologic diseases (ku) |
| Title: |
Drugs Used in the Treatment of Erectile Dysfunction. |
| Author: |
Eardley, I. |
| Source: |
IN: Eardley, I., et al, eds. Drug Treatment in Urology. Williston, VT: Blackwell Publishing Inc. 2006. pp. 39-61. |
| Availability: |
Available from Blackwell Publishing Inc. P.O.Box 20, Williston, VT 05495. Phone: 1-800-216-2522. Email: orders@aidcvt.com. Website: http://www .blackwellpublishing.com. Price: $99.95. |
| Abstract: |
This chapter on drugs used in the treatment of erectile dysfunction (ED) is from a book that offers a comprehensive summary of the role of pharmacology in urology. An introductory section reviews the physiology of erection, the causes of ED, and the principles of drug therapy to improve erectile function. The chapter then covers specific drugs, including the orally active phosphodiesterase type 5 (PDE5) inhibitors sildenafil, tadalafil, and vardenafil; centrally acting agents, notably apomorphine; and other occasionally-used oral agents, including phentolamine, yohimbine, and trazodone. The author then discusses the use of intracavernosal and intraurethral alprostadil, testosterone therapy, and agents currently under development. The author concludes that the PDE5 inhibitors remain the first line of therapy for most men with ED. Injectables are indicated following failure of initial oral therapy. 1 figure. 9 tables. 68 references. |
| Format: |
Book Chapter |
| Language: |
English. |
| Major Keywords: |
Urologic Diseases. Erectile Dysfunction. Drug Therapy. Drug Effects. Pharmacology. Patient Care Management. |
| Minor Keywords: |
Patient Selection. Administration and Dosage. Penis. Physiology. Sildenafil. Topical Administration. Symptoms. Alprostadil. Self Injection. Hormones. Testosterone. |
| Publication Number: |
KUBK11565. |
| Printer-Friendly Version | Return to Search Results |
|
<-- previous record
|
next record -->
|
|
 |
|
